News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Formatech, Inc. Donates Manufacturing Services to RegeneRx Biopharmaceuticals, Inc. (RGRX) to Produce Experimental Drug for the Treatment of Multiple Sclerosis


4/30/2010 9:08:03 AM

ANDOVER, Mass.--(BUSINESS WIRE)--Today, Formatech, Inc. announces the selection of RegeneRx Biopharmaceuticals, Inc.’s therapeutic product candidate RGN-352 as the next Fillanthropy™ Program candidate. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug candidate for use in clinical trials.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES